JASPREET VIRDI: Open Payments
NPI 1275811440 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,425 in 82 payments from 17 companies in 2025. Trend: 2023 $1,503 · 2024 $1,132 · 2025 $1,425
Food & beverage: $1,425
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 19 | $338 |
| Lilly USA, LLC | 11 | $197 |
| Novo Nordisk Inc | 14 | $175 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $160 |
| Abbott Laboratories | 9 | $155 |
| ABBVIE INC. | 5 | $99 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Sumitomo Pharma America, Inc. | 2 | $32 |
Products named: JARDIANCE, PREVNAR 20, FREESTYLE LIBRE 3, MOUNJARO, ELIQUIS, Ozempic, Wegovy, TRELEGY ELLIPTA.
Industry payments across OK — which companies pay providers there.
